Early research (Phase 1)Study completedNCT02220660
What this trial is testing
Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers
Who this might be right for
Healthy
Boehringer Ingelheim 32